Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to investigate whether inspiratory muscle training has an immediate effect on energy expenditure, heart rate, blood glucose, blood pressure, and arterial stiffness in healthy adults, obese adults, and adults with type 2 diabetes.
Participants will be asked to complete two trials involving intermittent exercise, which will include eupnea and inspiratory muscle training (IMT), as well as a resting control condition, in a randomized crossover study design. The trials will be separated by a minimum of 48 hours and will be completed within a 7-day period. Throughout all trials, participants will be required to remain relaxed and seated on an adjustable examination bed. For the IMT intensity, participants will utilize an inspiratory muscle training device (PowerBreathe Plus, Powerbreathe International Ltd., UK) and adjust the resistance to a level at which breathing continuously for 20 breaths is perceived as "somewhat hard" (RPE = 13), according to the Rating of Perceived Exertion (RPE) scale. This will take place during a 3.5-hour oral glucose tolerance test (OGTT). During the trials, participants may watch television or read; however, typing on a laptop or computer will be prohibited.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Eupnea | Experimental | Participants will breathe normally. |
|
| Inspiratory muscle training | Experimental | Intermittent inspiratory muscle training (IMT) will be conducted throughout the trial |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Eupnea | Behavioral | Participants will breathe normally. |
| |
| Intermittent inspiratory muscle training (IIMT) |
| Measure | Description | Time Frame |
|---|---|---|
| Blood glycaemic responses | Changes in blood glycaemic responses between trials | 0 (baseline), 30, 60, 120, and 210 minutes during the 210-minute trial |
| Pulse wave velocity (PWV) | Changes in pulse wave velocity between trials | 0 (baseline), 30, 60, 90, 150, and 210 minutes during the 210-minute trial |
| Measure | Description | Time Frame |
|---|---|---|
| Energy expenditure | Changes in energy expenditure between trials | First 90 minutes during the 210-minute trial |
| Heart Rate Variability (HRV) | Changes in Heart Rate Variability (HRV) between trials |
Not provided
Inclusion Criteria
Exclusion Criteria
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yung-Chih Chen, PhD | Contact | 02-77496979 | yc.chen@ntnu.edu.tw |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Behavioral |
Intermittent inspiratory muscle training (IIMT) will be conducted throughout the trial |
|
| In a regular patterns during the 210-minute trial |
| Visual analogue scale (VAS) | Changes in the visual analogue scale (VAS) ranged from 0 to 100 mm, with higher values indicating a greater intensity of sensation between trials. | Every 30 minutes during the 210-minute trial |
| Perceived stress scale (PSS) | Changes in perceived stress scale (PSS) with higher values indicating a greater intensity of sensation between trials. | Every 30 minutes during the 210-minute trial |